-+ 0.00%
-+ 0.00%
-+ 0.00%

Connect Biopharma Announces Promising Phase 2 Data for Rademikibart in Asthma and COPD, with Topline Results Expected in 1H 2026

Reuters·09/29/2025 13:00:41

Please log in to view news